Xin, Hongliang
Nanjing Medical University,
China
2024 Rank: 245477
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1944 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 245477 | 282620 |
| Total Cites | 429 | 443 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 60 | 60 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 237 | 242 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 364 | 374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.18 |
| Self-Citation Percentage |
3.16%
|
|
Xin, Hongliang
Nanjing Medical University,
China
2023 Rank: 279331
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2293 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 279331 | 316903 |
| Total Cites | 414 | 431 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 63 | 63 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 196 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 336 | 346 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
3.94%
|
|
Xin, Hongliang
Nanjing Medical University,
China
2022 Rank: 262832
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2128 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 262832 | 308201 |
| Total Cites | 401 | 408 |
| H-index | 12 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 62 | 62 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 162 | 165 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 329 | 334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.22 |
| Self-Citation Percentage |
1.72%
|
|
Xin, Hongliang
Nanjing Medical University,
China
2021 Rank: 261601
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 2103 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 261601 | 304434 |
| Total Cites | 583 | 602 |
| H-index | 14 | 14 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 116 | 117 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 250 | 255 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 473 | 486 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.24 |
| Self-Citation Percentage |
3.16%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.